AzTrials
AzTrials

Depression, AnxietyEMPOWERNCT06910748

An Online Guided Self-help Intervention to Improve Common Mental Health Problems Among Medical Professionals

A study testing E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.) and Education Materials in people with Depression, Anxiety, run by Chinese University of Hong Kong at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized controlled trial (RCT) aims to evaluate the effectiveness of an online guided self-help intervention developed based on Problem Solving Therapy (PST) and Acceptance and Commitment Therapy (ACT), which are both transdiagnostic low-intensity interventions recommended by the World Health Organization, in… Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Depression, Anxiety
What is being tested?
E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.) and Education Materials
Could I receive a placebo?
No, everyone receives an active treatment
How many people
161 participants
Where
1 siteHong Kong
Study dates
31 Mar 2025to 28 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • (1) being a frontline medical professional working in local public settings;
  • (2) at least 18 years of age;
  • (3) able to read and understand Chinese;
  • (4) have access to the Internet; and
  • (5) Patient Health Questionnaire (PHQ-9) and/or Generalized Anxiety Disorder (GAD-7) score>=5, indicating at least mild levels of depression and/or anxiety.

Who cannot join

  • actively suicidal.

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • JC School of Public Health and Primary Care, Faculty of Medicine, CUHK

    Hong Kong, China, No postal code

Other trials in Hong Kong

About this study

Official title: E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.) - An Online Guided Self-help Intervention to Improve Common Mental Health Problems Among Medical Professionals : A Randomized Controlled Trial

This randomized controlled trial (RCT) aims to evaluate the effectiveness of an online guided self-help intervention developed based on Problem Solving Therapy (PST) and Acceptance and Commitment Therapy (ACT), which are both transdiagnostic low-intensity interventions recommended by the World Health Organization, in improving medical professionals' mental health.

Read the detailed description

Despite the high prevalence of common mental health problems among medical professionals (MPs), their help-seeking for mental health support is low. Existing interventions are empirically effective but practically challenging to be applied in Hong Kong given the long intervention hours and fixed schedule. New interventions are needed to cater for the unique needs of local MPs.

Objectives: An online guided self-help intervention for MPs, E-training for Medical Professionals On Wellbeing and Effective Resolutions (the EMPOWER program), will be developed based on Problem Solving Therapy (PST) and Acceptance and Commitment Therapy (ACT), which are both transdiagnostic low-intensity interventions recommended by the World Health Organization. Targeted at local MPs aged 18-60 with depression and/or anxiety symptoms, the intervention aims to reduce their symptoms through strengthening coping skills for work-related problems. A randomized controlled trial (RCT) will be conducted to evaluate (1) the intervention's efficacy in reducing depression/anxiety compared with an active control (education pamphlets); (2) its efficacy in improving the levels of PTSD symptoms, well-being, burnout, and work performance versus active control; (3) the potential mediators/mechanisms explaining any between-group differences.

Method: 120 participants will be recruited online. The EMPOWER group will receive four 30-min self-paced weekly intervention sessions. The active control group will receive four weekly education pamphlets. Data will be collected at baseline, immediately post-intervention and 1-month follow-up. The group effect will be examined by comparing the mean improvement scores and remission rates on the outcome variables among the two groups. The potential mediation effects of problem solving and psychological flexibility between the two groups and the outcomes will also be tested.

Expected outcomes: The investigators expect (1) greater reductions in depression and/or anxiety as well as levels of PTSD, well-being, burnout, and work performance for the EMPOWER group at post-treatment and 1-month follow-up than active control, and that (2) the EMPOWER program will reduce depression and/or anxiety through enhancement in problem solving and psychological flexibility.

Implications: Findings can help to identify a cost-effective, flexible, and readily accessible mental health intervention for local MPs.

Being tested
E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.), Education Materials
Keywords
randomized controlled trial, medical professionals, internet-based, self-help, intervention, mental health, depression, anxiety
Medical subject headings
Depression, Anxiety Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.)Behavioural

    The EMPOWER programme aims to help participants acquire problem-solving skills adapted into the context of MPs' workplace and daily life to address their work-related, personal, and interpersonal problems, including self-neglect, work-life imbalance, patient communication problems, as well as stress during emerging public health crises. The session elements include video introduction, metaphors, daily examples, and narrative stories with prototype MP characters depicting the targeted problems to demonstrate how the taught problem-solving skills could be applied in a variety of situations. Brief exercise and homework will be assigned after each session and personalized written feedback will be provided. ACT strategies were also incorporated throughout the program to facilitate behavioral change.

  • Education MaterialsOther

    The active control receive education materials covering (1) introduction of mental health problems; (2) signs, symptoms, causes, and consequences of anxiety and depression, and (3) treatment approaches and available community resources.

Study groups in NCT06910748
Study groupRoleWhat they receive
The EMPOWER programExperimentalThe intervention group will receive 4 weekly sessions (the EMPOWER program).
Receives: Behavioral: E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.)
Education materialsActive comparatorThe active control group receive education materials about mental health, depression, anxiety and available community resources but not the EMPOWER program during the intervention period.
Receives: Other: Education Materials

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline depression immediately after the interventions

    The outcome will be measured by the Patient Health Questionnaire (PHQ) consisting of 9 questions designed to correspond to the 9 diagnostic criteria for major depressive disorder listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Items are rated from 0 to 3 according to increased frequency of experiencing difficulties in each area covered. Scores are summed and can range from 0 to 27. Score 10 is often recommended as the cut-off score to detect major depressive disorder. Scores of 5, 10, 15, and 20 represent cut-off points for mild, moderate, moderately severe, and severe depression, respectively. The Chinese version has been validated.

    Measured: immediately after the interventions

  2. Change from baseline depression 1 month after the interventions

    The outcome will be measured by the Patient Health Questionnaire (PHQ) consisting of 9 questions designed to correspond to the 9 diagnostic criteria for major depressive disorder listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Items are rated from 0 to 3 according to increased frequency of experiencing difficulties in each area covered. Scores are summed and can range from 0 to 27. Score 10 is often recommended as the cut-off score to detect major depressive disorder. Scores of 5, 10, 15, and 20 represent cut-off points for mild, moderate, moderately severe, and severe depression, respectively. The Chinese version has been validated.

    Measured: 1 month after the interventions

  3. Change from baseline anxiety immediately after the interventions

    The outcome will be measured by the Generalized Anxiety Disorder Scale (GAD), which is a 7-item instrument developed to identify likely cases of generalized anxiety disorder in primary care patients. Items are rated for the last two weeks, using a four-point rating scale for duration from 1 ("not at all") to 5 ("nearly every day"). A score of 10 or greater represents a cut point for identifying cases of generalized anxiety disorder, while cut points of 5, 10, 15, and 20 are interpreted as representing mild, moderate, moderately severe, and severe levels of anxiety. The Chinese version has been validated.

    Measured: Immediately after the interventions

  4. Change from baseline anxiety 1 month after the interventions

    The outcome will be measured by the Generalized Anxiety Disorder Scale (GAD), which is a 7-item instrument developed to identify likely cases of generalized anxiety disorder in primary care patients. Items are rated for the last two weeks, using a four-point rating scale for duration from 1 ("not at all") to 5 ("nearly every day"). A score of 10 or greater represents a cut point for identifying cases of generalized anxiety disorder, while cut points of 5, 10, 15, and 20 are interpreted as representing mild, moderate, moderately severe, and severe levels of anxiety. The Chinese version has been validated.

    Measured: 1 month after the interventions

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2025
  2. Study start31 Mar 2025
  3. Primary completion1 Apr 2026
  4. Study completion28 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
161 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06910748
Sponsor's protocol ID
1007627352
Acronym
EMPOWER
Status last verified
Jun 2026
First submitted
28 Mar 2025
Last updated
3 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing E-training for Medical Professionals On Wellbeing and Effective Resolutions (E.M.P.O.W.E.R.) and Education Materials in people with Depression, Anxiety, run by Chinese University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline depression immediately after the interventions (time frame: immediately after the interventions). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in